Works matching IS 15674215 AND DT 2022 AND VI 24

Results: 72
    1

    Heart Failure 2022.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, p. 1
    Publication type:
    Article
    2
    3
    4
    5
    6

    Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 581, doi. 10.1002/ejhf.2370
    By:
    • Amat-Santos, Ignacio J.;
    • Sánchez-Luna, Juan P.;
    • Abu-Assi, Emad;
    • Melendo-Viu, María;
    • Cruz-Gonzalez, Ignacio;
    • Nombela-Franco, Luis;
    • Muñoz-Garcí, Antonio J.;
    • Blas, Sergio G.;
    • de la TorreHernandez, Jose M.;
    • Romaguera, Rafael;
    • Sánchez-Recalde, Ángel;
    • Diez-Gil, José L.;
    • Lopez-Otero, Diego;
    • Gheorge, Livia;
    • Ibáñez, Borja;
    • Iñiguez-Romo, Andrés;
    • Raposeiras-Roubín, Sergio
    Publication type:
    Article
    7
    8

    Effects of an outpatient intervention comprising nurse-led non-invasive assessments, telemedicine support and remote cardiologists' decisions in patients with heart failure (AMULET study): a randomised controlled trial.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 565, doi. 10.1002/ejhf.2358
    By:
    • Krzesiński, Paweł;
    • Jankowska, Ewa A.;
    • Siebert, Janusz;
    • Galas, Agata;
    • Piotrowicz, Katarzyna;
    • Stańczyk, Adam;
    • Siwołowski, Paweł;
    • Gutknecht, Piotr;
    • Chrom, Paweł;
    • Murawski, Piotr;
    • Walczak, Andrzej;
    • Szalewska, Dominika;
    • Banasiak, Waldemar;
    • Ponikowski, Piotr;
    • Gielerak, Grzegorz
    Publication type:
    Article
    9
    10

    Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 551, doi. 10.1002/ejhf.2419
    By:
    • Curtain, James P.;
    • Jackson, Alice M.;
    • Li Shen;
    • Jhund, Pardeep S.;
    • Docherty, Kieran F.;
    • Petrie, Mark C.;
    • Castagno, Davide;
    • Desai, Akshay S.;
    • Rohde, Luis E.;
    • Lefkowitz, Martin P.;
    • Rouleau, Jean-Lucien;
    • Zile, Michael R.;
    • Solomon, Scott D.;
    • Swedberg, Karl;
    • Packer, Milton;
    • McMurray, John J. V.
    Publication type:
    Article
    11
    12

    Temporal trends in initiation of mineralocorticoid receptor antagonists and risk of subsequent withdrawal in patients with heart failure: a nationwide study in Denmark from 2003-2017.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 539, doi. 10.1002/ejhf.2418
    By:
    • Zahir, Deewa;
    • Bonde, Anders;
    • Madelaire, Christian;
    • Malmborg, Morten;
    • Butt, Jawad H.;
    • Fosbol, Emil;
    • Gislason, Gunnar;
    • Torp-Pedersen, Christian;
    • Andersson, Charlotte;
    • Rossignol, Patrick;
    • McMurray, John J. V.;
    • Kober, Lars;
    • Schou, Morten
    Publication type:
    Article
    13
    14
    15

    Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA-HF.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 513, doi. 10.1002/ejhf.2381
    By:
    • Butt, Jawad H.;
    • Docherty, Kieran F.;
    • Jhund, Pardeep S.;
    • de Boer, Rudolf A.;
    • Böhm, Michael;
    • Desai, Akshay S.;
    • Howlett, Jonathan G.;
    • Inzucchi, Silvio E.;
    • Kosiborod, Mikhail N.;
    • Martinez, Felipe A.;
    • Nicolau, Jose C.;
    • Petrie, Mark C.;
    • Ponikowski, Piotr;
    • Bengtsson, Olof;
    • Langkilde, Anna Maria;
    • Schou, Morten;
    • Sjöstrand, Mikaela;
    • Solomon, Scott D.;
    • Sabatine, Marc S.;
    • McMurray, John J. V.
    Publication type:
    Article
    16
    17

    Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 497, doi. 10.1002/ejhf.2403
    By:
    • Jackson, Alice M.;
    • Rørth, Rasmus;
    • Jiankang Liu;
    • Kristensen, Søren Lund;
    • Anand, Inder S.;
    • Claggett, Brian L.;
    • Cleland, John G. F.;
    • Chopra, Vijay K.;
    • Desai, Akshay S.;
    • Junbo Ge;
    • Jianjian Gong;
    • Lam, Carolyn S. P.;
    • Lefkowitz, Martin P.;
    • Maggioni, Aldo P.;
    • Martinez, Felipe;
    • Packer, Milton;
    • Pfeffer, Marc A.;
    • Pieske, Burkert;
    • Redfield, Margaret M.;
    • Rizkala, Adel R.
    Publication type:
    Article
    18
    19
    20
    21
    22
    23

    Changes in inferior vena cava area represent a more sensitive metric than changes in filling pressures during experimental manipulation of intravascular volume and tone.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 455, doi. 10.1002/ejhf.2395
    By:
    • Ivey-Miranda, Juan B.;
    • Wetterling, Friedrich;
    • Gaul, Robert;
    • Sheridan, Stephen;
    • Asher, Jennifer L.;
    • Rao, Veena S.;
    • Maulion, Christopher;
    • Mahoney, Devin;
    • Mebazaa, Alexandre;
    • Gray, Alastair P.;
    • Burkhoff, Daniel;
    • Cowie, Martin R.;
    • Cox, Zachary L.;
    • Butler, Javed;
    • Fudim, Marat;
    • McDonald, Kenneth;
    • Damman, Kevin;
    • Borlaug, Barry A.;
    • Testani, Jeffrey M.
    Publication type:
    Article
    24
    25

    Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 431, doi. 10.1002/ejhf.2397
    By:
    • Tomasoni, Daniela;
    • Fonarow, Gregg C.;
    • Adamo, Marianna;
    • Anker, Stefan D.;
    • Butler, Javed;
    • Coats, Andrew J. S.;
    • Filippatos, Gerasimos;
    • Greene, Stephen J.;
    • McDonagh, Theresa A.;
    • Ponikowski, Piotr;
    • Rosano, Giuseppe;
    • Seferovic, Petar;
    • Vaduganathan, Muthiah;
    • Voors, Adriaan A.;
    • Metra, Marco
    Publication type:
    Article
    26
    27

    Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 406, doi. 10.1002/ejhf.2414
    By:
    • de Boer, Rudolf A.;
    • Heymans, Stephane;
    • Backs, Johannes;
    • Carrier, Lucie;
    • Coats, Andrew J. S.;
    • Dimmeler, Stefanie;
    • Eschenhagen, Thomas;
    • Filippatos, Gerasimos;
    • Gepstein, Lior;
    • Hulot, Jean-Sebastien;
    • Knöll, Ralph;
    • Kupatt, Christian;
    • Linke, Wolfgang A.;
    • Seidman, Christine E.;
    • Tocchetti, C. Gabriele;
    • van der Velden, Jolanda;
    • Walsh, Roddy;
    • Seferovic, Petar M.;
    • Thum, Thomas
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    Reply to 'Epicardial adipose tissue: does it mediate the cardio-protective effects of sodium-glucose co-transporter 2 inhibitors in subjects with heart failure?' Letter regarding the article 'Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure'

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 2, p. 401, doi. 10.1002/ejhf.2423
    By:
    • De Biase, Nicolò;
    • Del Punta, Lavinia;
    • Pugliese, Nicola Riccardo
    Publication type:
    Article
    34
    35

    Epicardial adipose tissue: does it mediate the cardio-protective effects of sodium-glucose co-transporter 2 inhibitors in patients with heart failure? Letter regarding the article 'Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure'

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 2, p. 400, doi. 10.1002/ejhf.2412
    By:
    • Doumas, Michael;
    • Patoulias, Dimitrios;
    • Papadopoulos, Christodoulos
    Publication type:
    Article
    36
    37
    38
    39
    40
    41

    Worsening renal function in acute heart failure in the context of diuretic response.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 2, p. 365, doi. 10.1002/ejhf.2384
    By:
    • Emmens, Johanna E.;
    • Maaten, Jozine M. ter;
    • Yuya Matsue;
    • Figarska, Sylwia M.;
    • Sama, Iziah E.;
    • Cotter, Gad;
    • Cleland, John G. F.;
    • Davison, Beth A.;
    • Felker, G. Michael;
    • Givertz, Michael M.;
    • Greenberg, Barry;
    • Pang, Peter S.;
    • Severin, Thomas;
    • Gimpelewicz, Claudio;
    • Metra, Marco;
    • Voors, Adriaan A.;
    • Teerlink, John R.
    Publication type:
    Article
    42
    43
    44
    45
    46

    Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 1: overview and the central role for catecholamines and sympathetic nervous system

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 2, p. 257, doi. 10.1002/ejhf.2400
    By:
    • Omerovic, Elmir;
    • Citro, Rodolfo;
    • Bossone, Eduardo;
    • Redfors, Bjorn;
    • Backs, Johannes;
    • Bruns, Bastian;
    • Ciccarelli, Michele;
    • Couch, Liam S.;
    • Dawson, Dana;
    • Grassi, Guido;
    • Iacoviello, Massimo;
    • Parodi, Guido;
    • Schneider, Birke;
    • Templin, Christian;
    • Ghadri, Jelena R.;
    • Thum, Thomas;
    • Chioncel, Ovidiu;
    • Tocchetti, C. Gabriele;
    • van der Velden, Jolanda;
    • Heymans, Stephane
    Publication type:
    Article
    47
    48
    49
    50